Stephen Brown, NP

NPI: 1053464420
Total Payments
$7,464
2024 Payments
$2,770
Companies
14
Transactions
317
Medicare Patients
14
Medicare Billing
$5,190

Payment Breakdown by Category

Food & Beverage$7,283 (97.6%)
Education$180.82 (2.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,283 313 97.6%
Education $180.82 4 2.4%

Top Paying Companies

Company Total Records Latest Year
Teva Pharmaceuticals USA, Inc. $1,390 52 $0 (2024)
ITI, Inc. $984.30 46 $0 (2023)
Otsuka America Pharmaceutical, Inc. $967.28 41 $0 (2024)
Neurocrine Biosciences, Inc. $833.28 28 $0 (2024)
Janssen Pharmaceuticals, Inc $749.87 28 $0 (2024)
Indivior Inc. $632.66 44 $0 (2024)
Alkermes, Inc. $542.97 26 $0 (2024)
Lundbeck LLC $449.37 23 $0 (2024)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $431.80 10 $0 (2024)
Vanda Pharmaceuticals Inc. $172.89 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,770 101 Teva Pharmaceuticals USA, Inc. ($656.71)
2023 $1,956 90 Teva Pharmaceuticals USA, Inc. ($610.24)
2022 $1,388 60 Otsuka America Pharmaceutical, Inc. ($334.63)
2021 $1,350 66 ITI, Inc. ($522.69)

All Payment Transactions

317 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/12/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $21.16 General
12/10/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $23.01 General
Category: PSYCHIATRY
12/09/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $121.83 General
Category: Neuropsychiatry
12/06/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $29.17 General
Category: Neuropsychiatry
12/04/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $26.58 General
Category: Neuropsychiatry
11/23/2024 Lundbeck LLC ABILIFY MAINTENA (Drug) Food and Beverage Cash or cash equivalent $27.00 General
Category: PSYCHIATRY
11/22/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $26.71 General
Category: Neuroscience
11/12/2024 Lundbeck LLC ABILIFY MAINTENA (Drug) Food and Beverage Cash or cash equivalent $18.02 General
Category: PSYCHIATRY
11/05/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $22.55 General
11/01/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $32.70 General
Category: Neuropsychiatry
10/24/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $116.55 General
Category: PSYCHIATRY
10/23/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $23.83 General
Category: Neuropsychiatry
10/19/2024 Lundbeck LLC ABILIFY MAINTENA (Drug) Food and Beverage Cash or cash equivalent $31.25 General
Category: PSYCHIATRY
10/15/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Education In-kind items and services $27.27 General
Category: Psychiatry/Psychology
10/09/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $14.89 General
Category: Neuropsychiatry
10/08/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $25.78 General
Category: Central Nervous System
10/04/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $27.89 General
Category: Neuropsychiatry
09/30/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $30.88 General
Category: Neuropsychiatry
09/27/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $4.14 General
Category: Central Nervous System
09/26/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $15.76 General
Category: Central Nervous System
09/20/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $23.35 General
Category: Neuropsychiatry
09/10/2024 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $26.11 General
Category: Neuroscience
08/30/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $27.96 General
Category: PSYCHIATRY
08/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $34.43 General
Category: Neuropsychiatry
08/02/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $26.42 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2020 1 14 58 $15,821 $5,190
Total Patients
14
Total Services
58
Medicare Billing
$5,190
Procedure Codes
1

All Medicare Procedures & Services

1 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 14 58 $15,821 $5,190 32.8%

About Stephen Brown, NP

Stephen Brown, NP is a Nurse Practitioner healthcare provider based in Lynwood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1053464420.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephen Brown, NP has received a total of $7,464 in payments from pharmaceutical and medical device companies, with $2,770 received in 2024. These payments were reported across 317 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($7,283).

As a Medicare-enrolled provider, Brown has provided services to 14 Medicare beneficiaries, totaling 58 services with total Medicare billing of $5,190. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Other Specialties Family, Psychiatric/Mental Health
  • Location Lynwood, CA
  • Active Since 01/19/2007
  • Last Updated 07/24/2025
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1053464420

Products in Payments

  • CAPLYTA (Drug) $1,416
  • UZEDY (Drug) $1,038
  • ABILIFY MAINTENA (Drug) $864.03
  • INGREZZA (Drug) $833.28
  • INVEGA SUSTENNA (Drug) $722.84
  • PERSERIS (Drug) $627.66
  • REXULTI (Drug) $384.74
  • Austedo XR (Drug) $199.54
  • VIVITROL (Drug) $175.66
  • HETLIOZ (Drug) $172.89
  • LYBALVI (Drug) $132.19
  • Vivitrol (Drug) $121.35
  • ARISTADA (Drug) $113.77
  • LATUDA (Drug) $91.15
  • ABILIFY ASIMTUFII (Drug) $90.34
  • WAKIX (Drug) $65.17
  • ABILIFY MYCITE (Drug) $63.39
  • AUSTEDO (Drug) $57.80
  • VRAYLAR (Drug) $54.45
  • Wakix (Drug) $27.84

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Lynwood